Forte Biosciences, Inc.
CFO
CFO
Forte Biosciences, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Antony A. Riley is recorded as CFO at Forte Biosciences, Inc.. The proxy statement of Forte Biosciences, Inc. reports total compensation of $2,722,440 for Antony A. Riley in fiscal 2025, including a base salary of $452,109. Disclosed compensation is on record for 7 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Forte Biosciences, Inc.
CFO
Proxy statement
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
Forte Biosciences, Inc.
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Forte Biosciences, Inc. | Chief Financial Officer | $452,109 | $2,722,440 |
| 2024 | Forte Biosciences, Inc. | Chief Financial Officer | $434,730 | $856,875 |
| 2023 | Forte Biosciences, Inc. | Chief Financial Officer | $418,000 | $722,980 |
| 2022 | Forte Biosciences, Inc. | Chief Financial Officer | $380,000 | $610,278 |
| 2021 | Forte Biosciences, Inc. | Chief Financial Officer | $380,000 | $1,766,784 |
| 2020 | Forte Biosciences, Inc. | Chief Financial Officer | $264,075 | $1,056,250 |
| 2019 | Forte Biosciences, Inc. | Chief Financial Officer | — | — |
No call appearances or filed executive changes recorded yet.